Risk factors
NovoCure (NVCR) risk factors
Item 1A of every NovoCure Ltd. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors36 risks8 dropped6 reworded
Novocure restructured its risk disclosures by removing redundant headings on sales, reimbursement, patents, and convertible notes. Risk 34 was updated to disclose $200.0 million borrowed under a five-year senior secured credit facility as of December 31, 2025.
Filed Feb 26, 2026 - FY2024 10-K risk factors44 risks
NovoCure faces dominant risks centered on its history of operating losses, heavy reliance on third-party reimbursement, and extensive medical device regulatory oversight across multiple jurisdictions.
Filed Feb 27, 2025